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as	 to	 the	degree	of	detail.	Whereas	 some	expressed	a	 clear	desire	 for	procedural	
standards,	others	felt	that	it	would	be	sufficient	to	provide	only	general	directions.	





K E Y W O R D S
clinical	practice	guidelines,	patient	decision	aids,	patient	information,	patient	involvement,	
patient	participation,	patient	versions	of	guidelines,	quality	standards,	shared	decision	making
202  |     VAN DER WEIJDEN Et al.
1  | INTRODUC TION









summarize	 research	 evidence	 systematically	 and	 provide	 recom-
mendations	on	a	specific	clinical	topic.4	Nowadays,	the	GRADE	ap-
proach	 is	used	as	a	 framework	 to	 rate	 the	quality	of	 the	evidence	
and	to	assess	the	strength	of	the	recommendations	taking	into	ac-
count	 the	balance	between	benefits	 and	harms,	 resource	use	 and	
feasibility	considerations.	The	GRADE	method	also	recognizes	 the	






Next	 to	 patient	 participation	 on	 a	 collective	 level,	 efforts	 are	
made	 to	 adapt	 or	 enrich	 guidelines	 so	 as	 to	 facilitate	 patient	 par-
ticipation	on	an	individual	level,	in	clinical	decision	making.7	Patient	
participation	is	especially	important	in	case	of	preference-	sensitive	
decisions	where	multiple	 options	 exist	 or	where	 the	 benefits	 and	
harms	 of	 the	 intervention	may	 be	 assigned	 a	 different	 weight	 by	
different	patients.8	Illustrative	examples	to	facilitate	patient	partic-
ipation	 in	 clinical	 decision	making	 are	patient	 versions	of	 a	 guide-
line	 such	 as	 a	 lay	 summary,	 or	 patient	 decision	 aids	 for	 specific	
preference-	sensitive	decisions	attached	to	the	guideline	document.	
Some	 guidance	 for	 the	 content	 of	 lay	 summaries	 of	 guidelines	 is	
provided	by	the	Guidelines	 International	Network.9	 In	2006,	stan-
dards	were	 formulated	 for	 the	 content	of	patient	decision	aids	by	
the	 International	 Patient	 Decision	 Aids	 Standards	 (IPDAS)	 group,	
a	 multistakeholder	 process	 that	 led	 to	 a	 self-	assessment	 check-
list.10	Further	work	 led	to	a	measure	 IPDASi11	and	a	set	of	criteria	
that	should	be	met	to	achieve	a	“minimum”	acceptable	standard.12 










racy	 and	 effectiveness	 of	 medical	 information	 supplied	 via	 such	
tools.	Web	and	tool	designers	continue	to	introduce	ever	more	user-	
interface	friendly	tools.
For	 this	 study,	we	 used	 the	 following	 definition:	 a	 patient-	





during	 a	 clinical	 encounter.15	 Yet	 these	patient-	centred	 knowl-
edge	tools	are	subject	to	a	multitude	of	varying	definitions	and	
criteria,	especially	 regarding	the	patient	versions	of	guidelines,	




criteria,	 the	 need	 for	 national	 governance	 is	 also	 felt	 strongly,	
as	 many	 initiatives	 by	 patient	 organizations	 and	 professional	
bodies	 to	 develop	 patient-	directed	 knowledge	 tools	 exist	 side	
by	 side.	This	 situation	has	 resulted	 in	an	uncoordinated,	partly	
overlapping	 mixture	 of	 publicly	 and	 privately/commercially	
available	patient	decision	aids.23	Moreover,	some	of	the	patient	
decision	 aids	 do	 not	 seem	 to	 follow	 the	 rigid	 and	 multistake-
holder	methods	 to	 review	 the	 evidence	 base,	 as	 is	 common	 in	
clinical	practice	guidelines.





quality,	 reliable	 and	 publicly	 available	 patient-	directed	 knowledge	
tools,	which	will	contribute	to	achieving	properly	informed	patients	
and	shared	decision	making.
Initiated	 by	 the	 National	 Health	 Care	 Institute	 of	 the	





we	describe	 the	methods	used	 for	 arriving	at	 the	guidance	 as	 an	
illustrative	 example	 of	 how	 formal	 support	 from	 national	 stake-
holders	can	be	reached.	Second,	we	present	the	list	 (guidance)	of	








took	 the	position	 that	we	needed	various	 types	of	 input	and	pro-
cesses	to	ensure	a	successful	consensus	process.	To	this	end,	we	de-
signed	a	consortium	(see	first	four	authors	and	last	two	authors)	that	
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In	 a	 12-	month	 project	 that	 started	 in	 October	 2015,	 we	
worked	 on	 the	 basis	 of	 four	 work	 packages	 (WPs):	 (WP1)	
Radboud	University	(MF)	reviewed	existing	criteria	 in	the	litera-
ture,	synthesizing	evidence	and	best	practices;	(WP2)	Maastricht	
University	 (TvdW,	 DD),	 the	 coordinating	 group,	 developed	 the	












a	 first	 selection	of	 the	search	based	on	 title	and	abstract,	and	ex-
cluded	references	clearly	not	fulfilling	the	inclusion	criteria.	All	full-	
text	versions	that	resulted	from	this	first	selection	were	downloaded	
























•	 Papers	 describing	 the	 development	 of	 tools	 on	 other	 decisions	
than	medical	decisions.
(WP2)	 The	 project	was	 coordinated	 via	monthly	meetings	 of	 all	















with	 inflammatory	 bowel	 disease.	 Four	 projects	 focused	 on	 de-
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example	 in	 the	care	 for	orthopaedic	patients.	For	 the	 third	draft	


















at	 collecting	 the	experts’	 suggestions,	 for	which	43	 stakeholders	






consensus	meeting	was	 held	 in	 September	 2016,	 for	which	 only	
the	 formal	 representatives	 of	 patients,	 healthcare	 providers	 and	
healthcare	insurers	were	invited	in	order	to	gain	formal	support.
3  | RESULTS
3.1 | How did we arrive at the guidance?
3.1.1 | (WP1) Inventory of existing methods and 
criteria in scientific and grey literature
We	 found	51	hits	 in	PubMed,	of	which	 four	 studies	were	 included	

















3.1.2 | (WP3) Feasibility assessment in on-going 
development projects
While	 reactions	 to	 the	 ordering	 of	 the	 development	 steps	 in	 the	
draft	guidance	were	unanimously	positive,	the	project	leaders	were	
extremely	 divided	 as	 to	 the	 degree	 of	 detail	when	 it	 came	 to	 the	
instructions	within	 the	steps	of	 the	guidance,	 such	as	how	best	 to	
map	 the	patient	perspective	 in	 the	scoping	and	needs	assessment	
phase.	Whereas	some	project	 leaders	expressed	a	clear	desire	 for	












underestimated.	 Due	 to	 limitations	 in	 resources	 and	 the	 high	
workload,	work	should	not	be	done	twice,	 in	the	guideline	work-
ing	group	and	 in	 the	patient	 tool	development	group.	Moreover,	
the	 required	 minimum	 number	 of	 two	 patients	 in	 the	 team—as	
was	prescribed	in	the	earlier	drafts—was	a	concern,	as	well	as	the	
Box  1 The  Dutch  definitions  of  the  patient- directed 
knowledge tools24,25
Patient information based on a guideline	 (=patient	 version	 of	 a	




Summary of guideline:	Concise	overview	of	 the	guideline,	pro-
viding	 main	 conclusions	 and	 recommendations	 in	 clear	 and	
simple	language;	can	be	applied	in	practice	independently	from	
the	guideline;	intended	for	both	care	providers	and	patients.
Patient decision aid (PDA):	Auxiliary	information	and	answers	to	





and	 their	 likelihood	 of	 occurring;	 helps	 patients	 to	 weigh	 up	
their	options	based	on	their	own	values,	standards	and	personal	
circumstances.









3.1.3 | (WP4) The consensus meetings
For	the	first	meeting,	28	out	of	43	invited	experts	were	present.	
When	asked	to	mark	the	most	important	sections	of	the	guidance,	








stakeholders	 were	 well	 represented.	 In	 general,	 they	 expressed	 a	
positive	attitude	towards	the	guidance	although	two	critical	remarks	
were	made.	Firstly,	multiple	stakeholders	emphasized	to	widen	the	
scope	 of	 the	 guidance	 so	 that	 patient-	directed	 knowledge	 tools	
can	 also	 be	 developed	 on	 topics	 that	 are	 not	 covered	 by	 clinical	
practice	 guidelines,	 especially	 patient	 organizations	 claimed	 that	
the	 information	 needs	 of	 patients	 should	 determine	 the	 content	
of	 patient-	directed	 knowledge	 tools,	 as	 opposed	 to	 only	 follow-





declined	while	 giving	 blind	 consent	 to	 the	 guidance	 as	 a	 token	 of	
trust	in	the	representatives	of	the	patients	and	providers.	Therefore,	
the	 final	meeting	was	 attended	 by	 four	 participants,	 representing	
the	 Dutch	 Federation	 of	 Patients’	 Organisations	 (HP),	 the	 Dutch	
College	 of	 General	 Practitioners	 (TD),	 the	 Dutch	 Association	 of	
















WP1	 provided	 rich	 data	 for	 formulating	 eight	 distinct	 development	




Typical of patient information on a 
guideline(s) Development steps
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(such	as	a	lay	summary	or	decision	aid)	best	fits	the	objectives	of	the	











mendation)	 is	part	of	a	guideline	project,	 the	development	 team	will	
ideally	be	commissioned	by	the	guideline	working	group	itself.
For	patient	versions	of	guidelines,	the	patients’	information	needs	












We	 successfully	 collaborated	 as	 a	 consortium	 of	 researchers	 and	
end-	user	representatives,	with	patient	participation	achieved	at	the	
highest	 level	 of	 involvement,	 to	 achieve	 formal	 support	 from	 na-
tional	stakeholders	on	a	set	of	minimum	criteria	for	the	development	




A	 number	 of	 potential	 limitations	 should	 be	 mentioned.	 Our	











this	project	 is	 the	 systematic	 approach	and	 involvement	of	 all	 na-
tional	stakeholders,	from	patients	to	policymakers,	with	patient	rep-
resentatives	 in	a	co-	leading	 role.	We	believe	 that	 the	 involvement	



















ance	as	a	 further	 step	 towards	ensuring	 the	development	of	high-	











Formal	 steps	 towards	 accreditation	 have	 not	 yet	 been	 taken,	 the	
question	being	whether	this	procedure	is	needed	and	is	warranted	given	








We	 believe	 that	 this	 study	 can	 be	 seen	 as	 an	 inspirational	
example	for	other	countries	that	are	facing	the	same	challenges	
with	 regard	 to	 the	 development	 and	 governance	 of	 clinician-	
directed	 and	 patient-	directed	 knowledge	 tools	 such	 as	 guide-
lines,	 guideline	 summaries,	 patient	 versions	 of	 guidelines	 and	
patient	decision	aids.
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